This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through November 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
ad-tech: Archive
Can Pinterest's Latest Visual Search Ads Boost Its Market Position?
by Zacks Equity Research
PINS' Visual Search Ads connect commercial intent with visual discovery, giving brands new ways to reach shoppers closer to purchase.
PINSPositive Net Change SNAPPositive Net Change METANegative Net Change
ad-tech artificial-intelligence automation social-media tech-stocks
Chagee Holdings Limited - Sponsored ADR (CHA)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CHANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
The Trade Desk vs. Amazon: Which Ad-Tech Stock Is the Smarter Pick?
by Vaishali Doshi
AMZN's ad revenues jump 26% in Q2 as TTD's growth slows to 3%, sharpening the contrast amid rising CTV and retail media momentum.
AMZNNegative Net Change TTDPositive Net Change
ad-tech tech-stocks
Should You Buy PMV Pharmaceuticals, Inc. (PMVP) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PMVPPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
TTD Expands Pharma Reach: Can New Healthcare Integrations Drive Growth
by Shreya Majumder
TTD is expanding healthcare advertising with Veeva Crossix and IQVIA integrations, giving pharma advertisers more granular measurement and media optimization.
TTDPositive Net Change MGNIPositive Net Change PUBMPositive Net Change
ad-tech artificial-intelligence biotechnology pharmaceuticals smart-health tech-stocks
Buy These 4 Stocks With Robust Net Profit Margins to Boost Returns
by Anirudha Bhagat
Let's take a look at four stocks, QNST, TPC, HURN and EDRY, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.
HURNPositive Net Change QNSTPositive Net Change TPCPositive Net Change EDRYPositive Net Change
ad-tech construction home-builder
KANZHUN LIMITED Sponsored ADR (BZ) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
BZNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
TTD's International Expansion: Can EMEA and APAC Drive Growth?
by Zacks Equity Research
The Trade Desk's international expansion gains momentum as EMEA and APAC growth, rising CTV demand and China's surge open new opportunities.
TTDPositive Net Change MGNIPositive Net Change PUBMPositive Net Change
ad-tech artificial-intelligence business-services emerging-markets tech-stocks
Belite Bio, Inc. Sponsored ADR (BLTE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
BLTENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
TTD Stock Plunges 60% Year to Date: Time to Cut Losses and Exit?
by Vaishali Doshi
TTD has plunged 60.3% YTD as revenue growth slows amid soft ad demand across key categories despite long-term growth opportunities.
TTDPositive Net Change AMZNNegative Net Change GOOGLPositive Net Change PUBMPositive Net Change
ad-tech tech-stocks